Form 4: Bpifrance Group Sells Over 3.3M DBV Technologies Shares

The Bpifrance group, a 10% owner of DBV Technologies S.A., reported the sale of over 3.3 million ordinary shares across multiple transactions in mid-December 2025.

Summary

• Bpifrance Participations S.A., part of the Bpifrance group (a 10% owner of DBV Technologies S.A.), sold a total of 3,369,093 ordinary shares.
• On December 17, 2025, 2,036,990 ordinary shares were sold at a weighted average price of $4.84 per share, with prices ranging from $4.24 to $5.23.
• Also on December 17, 2025, an additional 40,000 ordinary shares were sold at a weighted average price of $5.28 per share.
• On December 18, 2025, 1,292,103 ordinary shares were sold at a weighted average price of $4.19 per share, with prices ranging from $3.79 to $4.32.
• Following these transactions, Bpifrance Participations S.A. indirectly beneficially owns 7,303,369 ordinary shares.
• Innobio FPCI, a fund managed by Bpifrance Investissement S.A.S. (also part of the Bpifrance group), indirectly owns 226,133 ordinary shares.
• All reported transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 3

Explanation: The substantial sale of shares by a major institutional shareholder group, Bpifrance, indicates a potential lack of confidence or a strategic divestment, which is generally viewed negatively by the market.

Negatives

• A significant portion of shares (over 3.3 million) were sold by a major institutional shareholder group, which can signal a lack of confidence or a strategic divestment.

Future Outlook

No forward-looking statements or guidance are provided.

Industry Context

Insider selling by a significant institutional investor can influence market perception, potentially signaling a shift in investment strategy or a perceived change in the company's prospects within the biotechnology sector.

Related Party Transactions

• The filing details sales of ordinary shares by the Bpifrance group, a 10% owner of DBV Technologies S.A., which constitutes a related party transaction.

Stakeholder Impact

• Shareholders may perceive the significant sales by a major institutional investor as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.

Key Dates

Recommendation

The significant divestment by a major institutional shareholder group, Bpifrance, suggests a potential loss of confidence or a strategic move away from DBV Technologies. Such large-scale insider selling often precedes further stock price declines as it signals a lack of conviction from those with deep insight into the company's prospects. Investors should consider reducing their exposure.

Keywords

DBV Technologies, DBVT, Bpifrance, insider selling, Form 4, beneficial ownership, equity sales, institutional investor, Rule 10b5-1